Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)-Reference-Cited by-同舟云学术

Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)

Published:2013-07 Issue:1 Volume:64 Page:150-158
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Templeton Arnoud J.,Dutoit Valérie,Cathomas Richard,Rothermundt Christian,Bärtschi Daniela,Dröge Cornelia,Gautschi Oliver,Borner Markus,Fechter Eva,Stenner Frank,Winterhalder Ralph,Müller Beat,Schiess Ralph,Wild Peter J.,Rüschoff Jan H.,Thalmann George,Dietrich Pierre-Yves,Aebersold Ruedi,Klingbiel Dirk,Gillessen Silke

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Mottet;Eur Urol,2011

3. Mechanisms of androgen-refractory prostate cancer;Debes;N Engl J Med,2004

4. Integrative genomic profiling of human prostate cancer;Taylor;Cancer Cell,2010

5. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition;Dunlop;Cell Signal,2009

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy;Prostate Cancer and Prostatic Diseases;2024-01-31

2. Identification of common factors among fibrosarcoma, rhabdomyosarcoma, and osteosarcoma by network analysis;Biosystems;2024-01

3. Pharmacoproteomics and Cancer Management;Pharmacoproteomics;2024

4. Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer;Biomedicine & Pharmacotherapy;2023-12

5. New Drug Discovery;Multidisciplinary Applications of Natural Science for Drug Discovery and Integrative Medicine;2023-06-16